NEW YORK (GenomeWeb News) – GE today said that it has named Sue Siegel, a former president of Affymetrix, to serve as CEO of its healthymagination initiative.

Siegel joins GE from Mohr Davidow Ventures, where she was a general partner leading investments in technology paltforms such as molecular diagnostics and digital health. She takes over the CEO role from Mike Barber, who led the initiative since 2009 but has been named VP and general manager of molecular imaging at GE Healthcare.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.